Research partnerships and support services
PGNI welcomes research collaborations, sponsored and foundation-supported studies, federal research partnerships, and institutional partnerships, alongside IRB reliance agreements and research support services for institutions.
Research partnerships and funding
PGNI welcomes research collaborations and externally funded research in pharmacogenomics. Whether you are an investigator, an institution, a sponsor, or a funder, there is a way to work together.
Investigator collaborations
Co-investigator roles and joint studies with academic, clinical, and independent researchers working in pharmacogenomics.
Sponsored research
Organizations that commission or sponsor pharmacogenomics studies, with PGNI as a research partner under independent ethical oversight.
Foundation-supported research
Joint proposals to foundations that fund pharmacogenomics, implementation, and health-equity research.
Federal research opportunities
Partnering on federally funded proposals and projects in pharmacogenomics, with attention to underserved and underrepresented populations.
Research support services
PGNI provides pharmacogenomic research support, including study design, data analysis, and model validation, for hospitals, universities, laboratories, companies, and independent researchers. Research services are provided separately from IRB review. Validation and analysis work is for research use only.
Organizations and researchers
- Hospitals and medical centers
- Pharmacies and pharmacy organizations
- Universities and research centers
- Laboratories
- Public health and community organizations
- AI, data, and engineering teams
- Pharmaceutical, biotechnology, and biomarker companies
- Drug-safety and toxicology teams
- Regulatory, compliance, and legal teams
- Nutrition and natural-products researchers
- Clinical trial sponsors
- Independent researchers
- Students
- Early-career researchers
Discounted pricing is available for researchers from pharmacogenomics-underrepresented and underserved populations, consistent with PGNI's mission.
PGNI Research Services
- Study design and protocol development, including for clinical studies
- Informed consent and study documents
- Data analysis
- Pharmacogenomic research data interpretation
- Research pilots that put pharmacogenomic results into routine prescribing
- Validation of dose-prediction and reporting logic against real-world data
- Independent evaluation of AI models, including checks for bias across populations
- Regulatory and compliance support for pharmacogenomic research, including consent and data governance
- Drug-safety and pharmacovigilance evidence reviews and analyses
- Population and health-equity analyses, including genomic diversity and underserved populations
- Evidence reviews and white papers
- Grant and manuscript support
- Custom training for organizations and research teams, and a research fellowship program for professionals
- IRB review for human-subjects studies, provided separately
Other ways to work with PGNI
IRB reliance agreements
Outside institutions can rely on PGNI's IRB as IRB of record for pharmacogenomics-related human-subjects research, through a formal reliance agreement.
See the IRB pageBecome an Affiliated Researcher
Individual researchers, including PGNI alumni, can join PGNI's research community and gain ongoing access to PGNI's IRB.
See ResearchEducation and training
A research fellowship program and courses, custom training for hospitals, pharmacy organizations, universities, laboratories, and companies, and curriculum partnerships with schools and training programs.
See EducationInstitutional partnerships
Universities, health systems, and professional organizations can partner with PGNI at the institutional level, typically under a memorandum of understanding, which can include shared research projects, education, and IRB reliance. If you have an idea for working together, reach out.